美股周二早盘,医疗技术公司Elevance Health(ELV)股价下跌1%,此前该公司公布第三季度业绩,非GAAP每股收益为6.03美元,比预期高出1.09美元。尽管医疗补助计划会员人数有所减少,但在更高的保费收益率和联邦医疗保险优势计划会员增长的推动下,营收同比增长12.1%至500.9亿美元。
责任编辑:张俊 SF065
美股周二早盘,医疗技术公司Elevance Health(ELV)股价下跌1%,此前该公司公布第三季度业绩,非GAAP每股收益为6.03美元,比预期高出1.09美元。尽管医疗补助计划会员人数有所减少,但在更高的保费收益率和联邦医疗保险优势计划会员增长的推动下,营收同比增长12.1%至500.9亿美元。
责任编辑:张俊 SF065
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.